InvestorsHub Logo
Followers 95
Posts 11597
Boards Moderated 0
Alias Born 12/27/2011

Re: Flair09 post# 3160

Wednesday, 10/04/2017 11:23:18 PM

Wednesday, October 04, 2017 11:23:18 PM

Post# of 9949
GW Pharmaceuticals still hasn't gotten FDA approval and they lose money each quarter yet they're trading at $110/share. I'm beginning to think InMed might beat them to market LOL

In any event, it shows that they don't have to be generating drug revenues, particularly if they can commercialize their biosynthesis or bioinformatics processes. As they complete each step (e.g. each clinical trial) and show progress toward revenues and profitability, the pps will head up to a higher level.

Les

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INM News